CEN Biotech, Inc.
CENBF
$0.0001
$0.000.00%
OTC PK
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -30.68% | 511.11% | 16,800.00% | 10,068.42% | 71,166.67% |
| Total Receivables | -72.20% | -- | 1,012.29% | 1,176.54% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 470.59% | 46.86% | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -24.29% | 546.70% | 1,952.94% | 2,284.85% | 132,200.00% |
|
|
|||||
| Total Current Assets | -24.29% | 546.70% | 1,952.94% | 2,284.85% | 132,200.00% |
| Net Property, Plant & Equipment | -35.42% | -- | -- | -- | -- |
| Long-term Investments | 13.17% | -- | -- | -- | -- |
| Goodwill | 13.17% | -- | -- | -- | -- |
| Total Other Intangibles | -8.72% | 4.83% | 2.85% | 2.34% | 4.28% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.60% | -1.21% | 6.00% | 0.65% | -10.09% |
| Total Assets | -5.83% | 31.27% | 33.97% | 33.68% | 28.12% |
|
|
|||||
| Total Accounts Payable | 30.52% | 74.20% | 107.68% | 172.12% | 63.42% |
| Total Accrued Expenses | -3.78% | 0.17% | 13.37% | 14.53% | -71.84% |
| Short-term Debt | -8.39% | 75.60% | 98.94% | 100.73% | -68.21% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -27.90% | -55.81% | -78.57% | -78.45% | -67.10% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -9.60% | -8.79% | -33.60% | -32.95% | -68.60% |
|
|
|||||
| Total Current Liabilities | -9.60% | -8.79% | -33.60% | -32.95% | -68.60% |
| Long-Term Debt | -2.55% | 31.67% | -46.14% | -59.49% | -92.65% |
| Short-term Debt | -8.39% | 75.60% | 98.94% | 100.73% | -68.21% |
| Capital Leases | -28.89% | 25.16% | 33.88% | 45.53% | 61.60% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -50.71% |
| Total Liabilities | -12.75% | -10.75% | -38.59% | -38.07% | -68.02% |
|
|
|||||
| Common Stock & APIC | 9.94% | 17.14% | 157.49% | 159.77% | 142.49% |
| Retained Earnings | -7.05% | -7.86% | -66.96% | -69.86% | 4.98% |
| Treasury Stock & Other | 19.37% | -- | -- | -- | -- |
| Total Common Equity | 31.62% | 62.66% | 81.68% | 83.41% | 89.51% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 31.62% | 62.66% | 81.68% | 83.41% | 89.51% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 31.62% | 62.66% | 81.68% | 83.41% | 89.51% |
|
|
|||||